The global Alpha Particle Targeted Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The North American market for Alpha Particle Targeted Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Alpha Particle Targeted Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Alpha Particle Targeted Therapy in Basic Radiochemistry is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Alpha Particle Targeted Therapy include Fusion Pharma, Bayer, Roche, Novartis, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Alpha Particle Targeted Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Alpha Particle Targeted Therapy. The Alpha Particle Targeted Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Alpha Particle Targeted Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Alpha Particle Targeted Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Alpha Particle Targeted Therapy Market Report

Report Metric	Details
Report Name	Alpha Particle Targeted Therapy Market
Segment by Type	Antibodies Peptides or Small Molecules
Segment by Application	Basic Radiochemistry Clinical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Fusion Pharma, Bayer, Roche, Novartis, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, AstraZeneca, AdvanCell
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Alpha Particle Targeted Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Alpha Particle Targeted Therapy Market report?

Ans: The main players in the Alpha Particle Targeted Therapy Market are Fusion Pharma, Bayer, Roche, Novartis, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, AstraZeneca, AdvanCell

What are the Application segmentation covered in the Alpha Particle Targeted Therapy Market report?

Ans: The Applications covered in the Alpha Particle Targeted Therapy Market report are Basic Radiochemistry, Clinical Research

What are the Type segmentation covered in the Alpha Particle Targeted Therapy Market report?

Ans: The Types covered in the Alpha Particle Targeted Therapy Market report are Antibodies, Peptides or Small Molecules

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Antibodies

1.2.3 Peptides or Small Molecules

1.3 Market by Application

1.3.1 Global Alpha Particle Targeted Therapy Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Basic Radiochemistry

1.3.3 Clinical Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alpha Particle Targeted Therapy Market Perspective (2021–2032)

2.2 Global Alpha Particle Targeted Therapy Growth Trends by Region

2.2.1 Global Alpha Particle Targeted Therapy Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Alpha Particle Targeted Therapy Historic Market Size by Region (2021–2026)

2.2.3 Alpha Particle Targeted Therapy Forecasted Market Size by Region (2027–2032)

2.3 Alpha Particle Targeted Therapy Market Dynamics

2.3.1 Alpha Particle Targeted Therapy Industry Trends

2.3.2 Alpha Particle Targeted Therapy Market Drivers

2.3.3 Alpha Particle Targeted Therapy Market Challenges

2.3.4 Alpha Particle Targeted Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Alpha Particle Targeted Therapy Players by Revenue

3.1.1 Global Top Alpha Particle Targeted Therapy Players by Revenue (2021–2026)

3.1.2 Global Alpha Particle Targeted Therapy Revenue Market Share by Players (2021–2026)

3.2 Global Top Alpha Particle Targeted Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Alpha Particle Targeted Therapy Revenue

3.4 Global Alpha Particle Targeted Therapy Market Concentration Ratio

3.4.1 Global Alpha Particle Targeted Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alpha Particle Targeted Therapy Revenue in 2025

3.5 Global Key Players of Alpha Particle Targeted Therapy Head Offices and Areas Served

3.6 Global Key Players of Alpha Particle Targeted Therapy, Products and Applications

3.7 Global Key Players of Alpha Particle Targeted Therapy, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Alpha Particle Targeted Therapy Breakdown Data by Type

4.1 Global Alpha Particle Targeted Therapy Historic Market Size by Type (2021–2026)

4.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (2027–2032)

5 Alpha Particle Targeted Therapy Breakdown Data by Application

5.1 Global Alpha Particle Targeted Therapy Historic Market Size by Application (2021–2026)

5.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Alpha Particle Targeted Therapy Market Size (2021–2032)

6.2 North America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Alpha Particle Targeted Therapy Market Size by Country (2021–2026)

6.4 North America Alpha Particle Targeted Therapy Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Alpha Particle Targeted Therapy Market Size (2021–2032)

7.2 Europe Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Alpha Particle Targeted Therapy Market Size by Country (2021–2026)

7.4 Europe Alpha Particle Targeted Therapy Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Alpha Particle Targeted Therapy Market Size (2021–2032)

8.2 Asia-Pacific Alpha Particle Targeted Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2021–2026)

8.4 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Alpha Particle Targeted Therapy Market Size (2021–2032)

9.2 Latin America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Alpha Particle Targeted Therapy Market Size by Country (2021–2026)

9.4 Latin America Alpha Particle Targeted Therapy Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Alpha Particle Targeted Therapy Market Size (2021–2032)

10.2 Middle East & Africa Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2021–2026)

10.4 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fusion Pharma

11.1.1 Fusion Pharma Company Details

11.1.2 Fusion Pharma Business Overview

11.1.3 Fusion Pharma Alpha Particle Targeted Therapy Introduction

11.1.4 Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.1.5 Fusion Pharma Recent Development

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Alpha Particle Targeted Therapy Introduction

11.2.4 Bayer Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.2.5 Bayer Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Alpha Particle Targeted Therapy Introduction

11.3.4 Roche Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.3.5 Roche Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Alpha Particle Targeted Therapy Introduction

11.4.4 Novartis Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.4.5 Novartis Recent Development

11.5 Orano Med

11.5.1 Orano Med Company Details

11.5.2 Orano Med Business Overview

11.5.3 Orano Med Alpha Particle Targeted Therapy Introduction

11.5.4 Orano Med Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.5.5 Orano Med Recent Development

11.6 Oncoinvent AS

11.6.1 Oncoinvent AS Company Details

11.6.2 Oncoinvent AS Business Overview

11.6.3 Oncoinvent AS Alpha Particle Targeted Therapy Introduction

11.6.4 Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.6.5 Oncoinvent AS Recent Development

11.7 Perspective Therapeutics

11.7.1 Perspective Therapeutics Company Details

11.7.2 Perspective Therapeutics Business Overview

11.7.3 Perspective Therapeutics Alpha Particle Targeted Therapy Introduction

11.7.4 Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.7.5 Perspective Therapeutics Recent Development

11.8 Ablaze Pharma

11.8.1 Ablaze Pharma Company Details

11.8.2 Ablaze Pharma Business Overview

11.8.3 Ablaze Pharma Alpha Particle Targeted Therapy Introduction

11.8.4 Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.8.5 Ablaze Pharma Recent Development

11.9 ARTBIO

11.9.1 ARTBIO Company Details

11.9.2 ARTBIO Business Overview

11.9.3 ARTBIO Alpha Particle Targeted Therapy Introduction

11.9.4 ARTBIO Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.9.5 ARTBIO Recent Development

11.10 AstraZeneca

11.10.1 AstraZeneca Company Details

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Alpha Particle Targeted Therapy Introduction

11.10.4 AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.10.5 AstraZeneca Recent Development

11.11 AdvanCell

11.11.1 AdvanCell Company Details

11.11.2 AdvanCell Business Overview

11.11.3 AdvanCell Alpha Particle Targeted Therapy Introduction

11.11.4 AdvanCell Revenue in Alpha Particle Targeted Therapy Business (2021–2026)

11.11.5 AdvanCell Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Perspective Therapeutics

List of Tables

Table 1. Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Antibodies

Table 3. Key Players of Peptides or Small Molecules

Table 4. Global Alpha Particle Targeted Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Alpha Particle Targeted Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2021–2026

Table 7. Global Alpha Particle Targeted Therapy Market Share by Region (2021–2026)

Table 8. Global Alpha Particle Targeted Therapy Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Alpha Particle Targeted Therapy Market Share by Region (2027–2032)

Table 10. Alpha Particle Targeted Therapy Market Trends

Table 11. Alpha Particle Targeted Therapy Market Drivers

Table 12. Alpha Particle Targeted Therapy Market Challenges

Table 13. Alpha Particle Targeted Therapy Market Restraints

Table 14. Global Alpha Particle Targeted Therapy Revenue by Players (US$ Million), 2021–2026

Table 15. Global Alpha Particle Targeted Therapy Market Share by Players (2021–2026)

Table 16. Global Top Alpha Particle Targeted Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Alpha Particle Targeted Therapy Revenue, 2025

Table 17. Ranking of Global Top Alpha Particle Targeted Therapy Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Alpha Particle Targeted Therapy Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Alpha Particle Targeted Therapy, Headquarters and Area Served

Table 20. Global Key Players of Alpha Particle Targeted Therapy, Products and Applications

Table 21. Global Key Players of Alpha Particle Targeted Therapy, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Alpha Particle Targeted Therapy Market Size by Type (US$ Million), 2021–2026

Table 24. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2021–2026)

Table 25. Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2027–2032)

Table 27. Global Alpha Particle Targeted Therapy Market Size by Application (US$ Million), 2021–2026

Table 28. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2021–2026)

Table 29. Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2027–2032)

Table 31. North America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026

Table 33. North America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Alpha Particle Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032

Table 46. Fusion Pharma Company Details

Table 47. Fusion Pharma Business Overview

Table 48. Fusion Pharma Alpha Particle Targeted Therapy Product

Table 49. Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 50. Fusion Pharma Recent Development

Table 51. Bayer Company Details

Table 52. Bayer Business Overview

Table 53. Bayer Alpha Particle Targeted Therapy Product

Table 54. Bayer Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 55. Bayer Recent Development

Table 56. Roche Company Details

Table 57. Roche Business Overview

Table 58. Roche Alpha Particle Targeted Therapy Product

Table 59. Roche Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 60. Roche Recent Development

Table 61. Novartis Company Details

Table 62. Novartis Business Overview

Table 63. Novartis Alpha Particle Targeted Therapy Product

Table 64. Novartis Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 65. Novartis Recent Development

Table 66. Orano Med Company Details

Table 67. Orano Med Business Overview

Table 68. Orano Med Alpha Particle Targeted Therapy Product

Table 69. Orano Med Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 70. Orano Med Recent Development

Table 71. Oncoinvent AS Company Details

Table 72. Oncoinvent AS Business Overview

Table 73. Oncoinvent AS Alpha Particle Targeted Therapy Product

Table 74. Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 75. Oncoinvent AS Recent Development

Table 76. Perspective Therapeutics Company Details

Table 77. Perspective Therapeutics Business Overview

Table 78. Perspective Therapeutics Alpha Particle Targeted Therapy Product

Table 79. Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 80. Perspective Therapeutics Recent Development

Table 81. Ablaze Pharma Company Details

Table 82. Ablaze Pharma Business Overview

Table 83. Ablaze Pharma Alpha Particle Targeted Therapy Product

Table 84. Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 85. Ablaze Pharma Recent Development

Table 86. ARTBIO Company Details

Table 87. ARTBIO Business Overview

Table 88. ARTBIO Alpha Particle Targeted Therapy Product

Table 89. ARTBIO Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 90. ARTBIO Recent Development

Table 91. AstraZeneca Company Details

Table 92. AstraZeneca Business Overview

Table 93. AstraZeneca Alpha Particle Targeted Therapy Product

Table 94. AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 95. AstraZeneca Recent Development

Table 96. AdvanCell Company Details

Table 97. AdvanCell Business Overview

Table 98. AdvanCell Alpha Particle Targeted Therapy Product

Table 99. AdvanCell Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026

Table 100. AdvanCell Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Alpha Particle Targeted Therapy Picture

Figure 2. Global Alpha Particle Targeted Therapy Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Alpha Particle Targeted Therapy Market Share by Type: 2025 vs 2032

Figure 4. Antibodies Features

Figure 5. Peptides or Small Molecules Features

Figure 6. Global Alpha Particle Targeted Therapy Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Alpha Particle Targeted Therapy Market Share by Application: 2025 vs 2032

Figure 8. Basic Radiochemistry Case Studies

Figure 9. Clinical Research Case Studies

Figure 10. Alpha Particle Targeted Therapy Report Years Considered

Figure 11. Global Alpha Particle Targeted Therapy Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 12. Global Alpha Particle Targeted Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Alpha Particle Targeted Therapy Market Share by Region: 2025 vs 2032

Figure 14. Global Alpha Particle Targeted Therapy Market Share by Players in 2025

Figure 15. Global Alpha Particle Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Alpha Particle Targeted Therapy Revenue in 2025

Figure 17. North America Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 18. North America Alpha Particle Targeted Therapy Market Share by Country (2021–2032)

Figure 19. United States Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. Canada Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Europe Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Alpha Particle Targeted Therapy Market Share by Country (2021–2032)

Figure 23. Germany Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. France Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. U.K. Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Italy Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Russia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Ireland Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Asia-Pacific Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Alpha Particle Targeted Therapy Market Share by Region (2021–2032)

Figure 31. China Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Japan Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. South Korea Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Southeast Asia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. India Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Australia & New Zealand Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Latin America Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Alpha Particle Targeted Therapy Market Share by Country (2021–2032)

Figure 39. Mexico Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Brazil Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Middle East & Africa Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Alpha Particle Targeted Therapy Market Share by Country (2021–2032)

Figure 43. Israel Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Saudi Arabia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. UAE Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Fusion Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 47. Bayer Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 48. Roche Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 49. Novartis Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 50. Orano Med Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 51. Oncoinvent AS Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 52. Perspective Therapeutics Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 53. Ablaze Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 54. ARTBIO Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 55. AstraZeneca Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 56. AdvanCell Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions